{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:17:19Z","timestamp":1783430239655,"version":"3.54.6"},"reference-count":35,"publisher":"MDPI AG","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAPMA"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:p>Although effective, oral antifungal therapy is still not completely successful. Recent studies have shown that combination therapy with oral and topical agents offers an increased cure rate for patients. We review the main drug combinations that have been tested. Additional measures, such as mechanical intervention, may help improve response rates further. (J Am Podiatr Med Assoc 96(2): 116\u2013119, 2006)<\/jats:p>","DOI":"10.7547\/0960116","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T10:24:42Z","timestamp":1396347882000},"page":"116-119","source":"Crossref","is-referenced-by-count":23,"title":["Topical and Oral Combination Therapy for Toenail Onychomycosis"],"prefix":"10.3390","volume":"96","author":[{"given":"Ivan R.","family":"Bristow","sequence":"first","affiliation":[{"name":"School of Health Professions and Rehabilitation Sciences, University of Southampton, Southampton, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Baran","sequence":"additional","affiliation":[{"name":"Nail Disease Centre, Cannes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","reference":[{"key":"R1","series-title":"Mycoses","first-page":"496","volume":"46","year":"2003","unstructured":"Burzykowski G, Molenberghs D, Abeck E, et al: High prevalence of foot diseases in Europe: results of the Achilles project. .Mycoses46::496. ,2003. .14641624"},{"key":"R2","series-title":"Qual Life Res","first-page":"341","volume":"2","year":"1993","unstructured":"Lubeck D, Patrick D, McNulty P, et al: Quality of life of persons with onychomycosis. .Qual Life Res2::341. ,1993. .8136799"},{"key":"R3","series-title":"Int J Dermatol","first-page":"754","volume":"36","year":"1997","unstructured":"Elewski B: The effect of toenail onychomycosis on patient quality of life. .Int J Dermatol36::754. ,1997. .9372349"},{"key":"R4","series-title":"Br J Dermatol","first-page":"1","volume":"141","year":"1999","unstructured":"Roberts D: Onychomycosis: current treatment and future challenges. .Br J Dermatol141: (suppl 56):1. ,1999. .10730907"},{"key":"R5","series-title":"Br J Dermatol","first-page":"15","volume":"149","year":"2003","unstructured":"Olafsson JH, Sigurgeirsson B, Baran R: Combination therapy for onychomycosis. .Br J Dermatol149: (suppl 65):15. ,2003. ."},{"key":"R6","series-title":"Proc Soc Exp Biol Med","first-page":"571","volume":"138","year":"1971","unstructured":"Medoff G, Kobayashi G, Kwang C: Potentialisation of rifampicin and fluorocytosine as antifungal antibiotics by amphotericin B. .Proc Soc Exp Biol Med138::571. ,1971. .5118468"},{"key":"R7","series-title":"Mycoses","first-page":"355","volume":"42","year":"1999","unstructured":"Polak A: The past, present and future of antimycotic combination therapy. .Mycoses42::355. ,1999. .10536428"},{"key":"R8","series-title":"Br J Dermatol","first-page":"9","volume":"145","year":"2001","unstructured":"Evans EGV: The rationale for combination therapy. .Br J Dermatol145: (suppl 60):9. ,2001. .11777263"},{"key":"R9","series-title":"Clin Exp Dermatol","first-page":"175","volume":"12","year":"1987","unstructured":"Hay R, Clayton Y, Moore M: A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis. .Clin Exp Dermatol12::175. ,1987. .2961485"},{"key":"R10","doi-asserted-by":"publisher","year":"1999","unstructured":"Nolting S: \u201cOpen Studies of Ciclopirox Nail Lacquer in Onychomycosis: A Review,\u201d in Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis, ed by S Shuster, p 75, Springer-Verlag, Berlin. ,1999. .10.1007\/978-3-642-58401-5_13","DOI":"10.1007\/978-3-642-58401-5_13"},{"key":"R11","series-title":"Br J Dermatol","first-page":"296","volume":"149","year":"2003","unstructured":"Gupta AK, Kohli Y: In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. .Br J Dermatol149::296. ,2003. .12932235"},{"key":"R12","year":"2001","unstructured":"Baran R, Bohn M, Kraemer K, et al: Characterisation of interactions between systemic and topical antifungal agents. Poster presented at the American Academy of Dermatology 59th Annual Meeting, March 2\u20137. ,2001. , Washington, DC."},{"key":"R13","series-title":"JAMA (SEA)","first-page":"23","volume":"9","year":"1993","unstructured":"Lauharanta J, Zaug M, Polak A, et al: Combination of amorolfine with griseofulvin: in vitro activity and clinical results in onychomycosis. .JAMA (SEA)9: (suppl 4):23. ,1993. ."},{"key":"R14","series-title":"J Eur Acad Dermatol Venereol","first-page":"S23","volume":"4","year":"1995","unstructured":"Zaug M: Amorolfine nail lacquer: clinical experience in onychomycosis. .J Eur Acad Dermatol Venereol4: (suppl 1) :S23. ,1995. ."},{"key":"R15","series-title":"Br J Dermatol","first-page":"1177","volume":"142","year":"2000","unstructured":"Baran R, Feulhade M, Datry A, et al: A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the nail region. .Br J Dermatol142::1177. ,2000. .10848743"},{"key":"R16","series-title":"Mikol Lek","first-page":"47","volume":"8","year":"2001","unstructured":"Szepietowski J, Roiycka B: Combined therapy for onychomycosis. .Mikol Lek8::47. ,2001. ."},{"key":"R17","series-title":"J Eur Acad Dermatol Venereol","first-page":"40","volume":"17","year":"2003","unstructured":"Baran E, Bochenski J: Combined approach to onychomycosis management (abstract SP5-1). .J Eur Acad Dermatol Venereol17: (suppl 1):40. ,2003. ."},{"key":"R18","series-title":"Mikol Lek","first-page":"79","volume":"10","year":"2003","unstructured":"Baran E, Bochenski J, Duczkowski M, et al: Combination therapy for onychomycosis with amorolfine nail lacquer and oral antifungal agents. .Mikol Lek10::79. ,2003. ."},{"key":"R19","series-title":"Br J Dermatol","first-page":"21","volume":"145","year":"2001","unstructured":"Lecha M, Alsina M, Torres M, et al: Amorolfine and itraconazole combination for severe toenail onychomycosis: results of an open randomised trial in Spain. .Br J Dermatol145: (suppl 60):21. ,2001. .11777261"},{"key":"R20","series-title":"Prz Dermatol","first-page":"493","volume":"89","year":"2002","unstructured":"Maleszka R, Ratajczak V, Turek-Krasinska K, et al: The use of amorolfine in the treatment of dermatophyte onychomycosis. .Prz Dermatol89::493. ,2002. ."},{"key":"R21","series-title":"J Eur Acad Dermatol Venereol","first-page":"47","volume":"17","year":"2003","unstructured":"Adaskevich U, Evseenko I: Itraconazole in combined treatment of patients with onychomycosis (abstract PP1-1). .J Eur Acad Dermatol Venereol17: (suppl 1):47. ,2003. .12602968"},{"key":"R22","series-title":"Mycoses","first-page":"68","volume":"44","year":"2001","unstructured":"Sergeev Y, Sergeev A: Pulsed combination therapy: the new option for onychomycosis. .Mycoses44: (suppl 1):68. ,2001. ."},{"key":"R23","year":"1998","unstructured":"Sergeev A, Sergeev Y: Combined treatment of onychomycosis with fluconazole and amorolfine nail lacquer [abstract]. In Proceedings of the Fourth Congress of the European Confederation of Medical Mycology, Glasgow. ,1998. ."},{"key":"R24","series-title":"Br J Dermatol","first-page":"189","volume":"138","year":"1998","unstructured":"Roberts DT, Evans EG: Subungual dermatophytoma complicating dermatophyte onychomycosis. .Br J Dermatol138::189. ,1998. .9536247"},{"key":"R25","series-title":"Mycoses","first-page":"506","volume":"46","year":"2003","unstructured":"Seebacher C: Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis. .Mycoses46::506. ,2003. .14641625"},{"key":"R26","series-title":"Br J Dermatol","first-page":"358","volume":"72","year":"1960","unstructured":"Hargreaves G: The treatment of onychomycosis with griseofulvin. .Br J Dermatol72::358. ,1960. .13711555"},{"key":"R27","series-title":"Clin Exp Dermatol","first-page":"273","volume":"7","year":"1982","unstructured":"White MI, Clayton YM: The treatment of fungus and yeast infections of the nail by the method of \u201cchemical removal.\u201d. Clin Exp Dermatol7::273. ,1982. .7105479"},{"key":"R28","series-title":"Clin Exp Dermatol","first-page":"413","volume":"10","year":"1985","unstructured":"Baran R, Hay RJ: Partial surgical avulsion of the nail in onychomycosis. .Clin Exp Dermatol10::413. ,1985. .2934186"},{"key":"R29","series-title":"Hand Clin","first-page":"625","volume":"18","year":"2002","unstructured":"Baran R: Nail fungal infections and treatment. .Hand Clin18::625. ,2002. .12516977"},{"key":"R30","series-title":"Cutis","first-page":"609","volume":"25","year":"1980","unstructured":"South D, Farber E: Urea ointment in the non-surgical avulsion of nail dystrophies: a reappraisal. .Cutis25::609. ,1980. .7379590"},{"key":"R31","series-title":"Br J Dermatol","first-page":"402","volume":"148","year":"2003","unstructured":"Roberts DT, Taylor WD, Boyle J: Guidelines for treatment of onychomycosis. .Br J Dermatol148::402. ,2003. .12653730"},{"key":"R32","series-title":"Australas J Dermatol","first-page":"105","volume":"43","year":"2002","unstructured":"Murray SC, Dawber RPR: Onychomycosis of the toenails: podiatric and orthopaedic considerations. .Australas J Dermatol43::105. ,2002. .11982566"},{"key":"R33","series-title":"Br J Dermatol","first-page":"5","volume":"149","year":"2003","unstructured":"Scher R, Baran R: Onychomycosis in clinical practice: factors contributing to recurrence. .Br J Dermatol149: (suppl 65):5. ,2003. ."},{"key":"R34","series-title":"Int J Dermatol","first-page":"614","volume":"35","year":"1996","unstructured":"Zaias N, Rebell G: Chronic dermatophytosis syndrome due to Trichophyton rubrum.. Int J Dermatol35::614. ,1996. .8876284"},{"key":"R35","series-title":"J Am Acad Dermatol","first-page":"S96","volume":"43","year":"2000","unstructured":"Gupta AK, Baran R: Ciclopirox nail lacquer solution 8% in the 21st century. .J Am Acad Dermatol43::S96. ,2000. .11051138"}],"container-title":["Journal of the American Podiatric Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/96\/2\/0960116.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/japma\/article-pdf\/96\/2\/116\/1413264\/0960116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/96\/2\/0960116.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/96\/2\/0960116.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:46:18Z","timestamp":1783428378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1930-8264\/96\/2\/116"}},"subtitle":["An Updated Review"],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":35,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.7547\/0960116","relation":{},"ISSN":["8750-7315","1930-8264"],"issn-type":[{"value":"8750-7315","type":"print"},{"value":"1930-8264","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}